Drugmakers Allergan, with a $113 billion market capitalization, and Pfizer, which is valued at $219 billion, are discussing what could become this year’s biggest merger, sources say. Talks reportedly began after Pfizer approached Allergan with a proposal. Pfizer has been pursuing acquisitions recently.

Wall Street Journal (subscription needed)